{"created_at":"Fri Jun 12 12:36:28 +0000 2015","id":609338477512032256,"id_str":"609338477512032256","text":"Novartis' Arzerra extends progression-free survival by 54% in blood cancer http:\/\/t.co\/D6XGUUWY3j #premarket $NVS","source":"\u003ca href=\"http:\/\/seekingalpha.com\" rel=\"nofollow\"\u003eSeeking Alpha\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2999760448,"id_str":"2999760448","name":"Healthcare Stocks","screen_name":"SA_HealthInvest","location":"","url":"http:\/\/seekingalpha.com\/news\/healthcare","description":"Seeking Alpha's breaking news and analysis of healthcare stocks. For all SA Twitter feeds, see https:\/\/twitter.com\/SeekingAlpha\/following","protected":false,"verified":false,"followers_count":748,"friends_count":32,"listed_count":15,"favourites_count":0,"statuses_count":5777,"created_at":"Mon Jan 26 14:39:13 +0000 2015","utc_offset":10800,"time_zone":"Bucharest","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"360000","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/559722417979793408\/OsxfkvzX_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/559722417979793408\/OsxfkvzX_normal.png","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"premarket","indices":[98,108]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/D6XGUUWY3j","expanded_url":"http:\/\/seekingalpha.com\/news\/2577425-novartis-arzerra-extends-progression-free-survival-by-54-percent-in-blood-cancer?source=twitter_sa_healthinvest","display_url":"seekingalpha.com\/news\/2577425-n\u2026","indices":[75,97]}],"user_mentions":[],"symbols":[{"text":"NVS","indices":[109,113]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1434112588657"}
